We have a track record of working with top pharmaceutical corporations and leading academic institutions to foster valuable innovation. We are eager to collaborate closely with partners to broaden the impact of our REVEALâ„¢ Exosome Therapeutics platform across a diversity of disease areas.
We are excited to collaborate with companies with deep indication expertise and complementary capabilities in regenerative medicine, metabolic and cardiovascular disorders, rare diseases, neurodegenerative disease, and more.